EHMT2 and leukemia: Our particular interest is the PKMT G9a (also known as KMT1C, EHMT2), which is a histone 3 lysine 9 (H3K9) specific methyltransferase that is overexpressed in many cancers including leukemia, hepatocellular carcinoma and pulmonary carcinoma.